Origimm Biotechnology

ProVaDis: Protection-based Vaccine Discovery

ORIGIMM TO PRESENT AT THE WORLD VACCINE CONGRESS, NOVEMBER 2015, MADRID

World Vaccine Congress is a 3-day event with the aim to introduce and explore new technologies for vaccine discovery and development, and provide updates on the latest discovery-stage prophylactic and therapeutic vaccines in the pharmaceutical industry. Origimm will be presenting the advantages and the ‘proof-of-concept’ data of its ProVaDis technology in the New Technology and Discovery session.